joseph m. connors, md: optimizing therapy, minimizing toxicity in hodgkin lymphoma
Published 7 years ago • 310 plays • Length 6:56Download video MP4
Download video MP3
Similar videos
-
9:50
how i treat hodgkin lymphoma - joseph connors, md
-
6:24
joseph connors, md: bleomycin or brentuximab vedotin in hodgkin lymphoma?
-
6:09
conversations with innovators: joseph connors, md, on targeted therapy for hodgkin lymphoma
-
1:12
optimizing treatment in hodgkin lymphoma
-
2:25
warning signs of lymphoma
-
5:01
hodgkin lymphoma staging: from diagnosis to prognosis | the patient story
-
4:58
doctor explains warning symptoms and signs of hodgkin's lymphoma cancer
-
5:28
blood review series – update on hodgkin lymphoma
-
4:19
is the combo of abbreviated chemo plus radiation therapy a viable option for dlbcl patients?
-
7:18
addition of targeted drug reduces risk of first-line treatment failure in advanced hodgkin lymphoma
-
12:51
brentuximab vedotin plus avd: limiting toxicity in limited-stage hodgkin lymphoma
-
1:01
ask unmc: lymphoma treatments
-
3:15
the progress in treating hodgkin lymphoma
-
5:49
ash 2017 - joseph m connors interview
-
6:29
jonathan friedberg, md: treating highly aggressive lymphomas
-
1:48:44
hodgkin lymphoma: optimizing treatment in the era of targeted therapy
-
40:00
improving targeted therapies for patients with previously untreated advanced classic hodgkin lymphom
-
40:00
a new frontline treatment option for hodgekin lymphoma
-
1:09
dr. schmitt on a novel treatment approach to hodgkin lymphoma
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
10:20
the lymphoma tumor microenvironment: therapeutic targeting, genetics, drug optimization
-
6:59
doctor explains how hodgkin lymphoma spreads, plus risk factors & treatment options | stanford